15 - 16 October 2020 | PDT (UTC-7)
Join over 450 leaders, experts and scientists to discuss strategies to harness the immune system for the development of innovative therapeutics
Featuring over 40 presentations, the event brings together leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development
Over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools
Over 40 presentations and case studies focussed on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical research
15 October 2020 – Day One
16 October 2020 – Day Two
This event is co-located with the virtual event 5th Annual Biomarkers & Precision Medicine USA Congress.
Attendees will have full access to both events.
The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
The following were confirmed speakers for the 2019 series.
Oncternal Therapeutics
Nektar Therapeutics
Machavert Pharmaceuticals
Pfizer
Novartis
Pfizer
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
